Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion
Tessa Romero

Tessa Romero Analyst Performance

Senior Analyst - Biotechnology Equity Research at JPMorgan Chase & Co.

Tessa Romero is a stock analyst at JPMorgan Chase & Co. in the medical sector, covering 13 publicly traded companies. Over the past year, Tessa Romero has issued 31 stock ratings, including buy, hold, and sell recommendations. While full access to Tessa Romero's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tessa Romero's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
33 Last 1 Years
Buy Recommendations
72.73% 24 Buy Ratings
Companies Covered
13 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy72.7%24 ratings
Hold21.2%7 ratings
Sell6.1%2 ratings

Out of 33 total stock ratings issued by Tessa Romero at JPMorgan Chase & Co., the majority (72.7%) have been Buy recommendations, followed by 21.2% Hold and 6.1% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
92.3% of companies on NASDAQ
12 companies
NYSE
7.7% of companies on NYSE
1 company

Tessa Romero, an analyst at JPMorgan Chase & Co., currently covers 13 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
13 companies
100.0%

Tessa Romero of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
11 companies
84.6%
MED - DRUGS
2 companies
15.4%

Tessa Romero's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Oculis Holding AG stock logo
OCS
Oculis
5/18/2026Boost Price Target$28.94$42.00Overweight
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
5/12/2026Boost Price Target$74.56$97.00Overweight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/12/2026Boost Price Target$55.14$80.00Overweight
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
4/6/2026Boost Price Target$34.86$36.00Neutral
Septerna, Inc. stock logo
SEPN
Septerna
3/24/2026Boost Price Target$23.35$38.00Overweight
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
3/17/2026Boost Price Target$30.95$45.00Overweight
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
3/17/2026Boost Price Target$62.29$75.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
3/16/2026Boost Price Target$40.79$50.00Overweight
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
3/4/2026Boost Price Target$23.25$34.00Overweight
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
1/20/2026Lower Price Target$16.39$16.00Neutral
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
1/20/2026Boost Price Target$62.85$74.00Overweight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
1/9/2026Boost Price Target$41.22$62.00Overweight
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
1/6/2026Boost Price Target$27.43$25.00Neutral
Oculis Holding AG stock logo
OCS
Oculis
12/19/2025Initiated Coverage$19.48$38.00Overweight
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
11/21/2025Lower Price Target$24.67$20.00Neutral
Biohaven Ltd. stock logo
BHVN
Biohaven
11/20/2025Lower Price Target$9.55$15.00Overweight
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
11/18/2025Downgrade$2.98Underweight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
11/18/2025Boost Price Target$40.32$60.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
11/18/2025Boost Price Target$38.71$47.00Overweight
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
11/17/2025Lower Price Target$24.45$31.00Overweight
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
11/14/2025Lower Price Target$18.86$17.00Neutral
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
11/14/2025Boost Price Target$23.00$34.00Overweight
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
9/29/2025Lower Price Target$21.05$33.00Overweight
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
9/16/2025Downgrade$1.52Underweight
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
8/19/2025Lower Price Target$13.83$30.00Overweight
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
7/24/2025Boost Price Target$23.16$34.00Overweight
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
7/15/2025Lower Price Target$8.35$9.00Neutral
Biohaven Ltd. stock logo
BHVN
Biohaven
6/18/2025Lower Price Target$14.58$55.00Overweight
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
6/9/2025Lower Price Target$32.65$53.00Overweight
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/6/2025Boost Price Target$22.05$30.00Overweight
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
5/30/2025Lower Price Target$2.76$10.00Overweight
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
3/21/2025Lower Price Target$12.18$17.00Neutral
Biohaven Ltd. stock logo
BHVN
Biohaven
3/5/2025Lower Price Target$30.90$68.00Overweight